itpc mena > Ressources > Analysis
Analysis
Latest addition : 10 February 2012.
What future for India’s Patent Act? [MSF]
12 October 2011What future for India’s Patent Act? Médecins Sans Frontières - Video Update on Novartis vs. Union of India, Cancer Patients Aid Association & others in relation to the interpretation of Section 3(d) of the Indian Patent Act: Swiss pharmaceutical company Novartis took the Indian government to court five years ago, in an effort to overturn Section 3(d) of the country’s Patent Act that was (...)
What Novartis says…and why it’s wrong [MSF]
12 October 2011BACKGROUND: The Supreme Court case is the final act in a legal battle over the patentability of the salt form of the anti-cancer drug imatinib and section 3(d) of the Indian patent law that stretches back over five years. In 2006, the Indian patents office ruled that Novartis did not deserve a patent for imatinib mesylate, a salt form of a life-saving cancer drug, on the grounds that the (...)
Guerre contre les usagers de drogues - Accès aux traitements et répression en Thaïlande [VACARME]
20 September 2011Texte publié au printemps 2011 dans la Revue Vacarme par Pauline Londeix & Jérôme Martin Les usagers de drogue en Thaïlande sont victimes d’une double cécité. Cécité du gouvernement qui refuse de mettre en place une politique de soins adéquate. Cécité des laboratoires pharmaceutiques qui refusent de mettre à disposition des plus démunis les médicaments qui seraient, seuls, en mesure de les soigner (...)
RSS 2.0